Fiduciary Management Inc. WI Raises Stake in Henry Schein, Inc. (NASDAQ:HSIC)

Fiduciary Management Inc. WI grew its position in Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 7.2% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 2,488,335 shares of the company's stock after acquiring an additional 167,990 shares during the period. Henry Schein accounts for approximately 1.6% of Fiduciary Management Inc. WI's investment portfolio, making the stock its 23rd biggest position. Fiduciary Management Inc. WI owned 2.00% of Henry Schein worth $172,193,000 at the end of the most recent reporting period.

Several other hedge funds also recently modified their holdings of the company. Forum Financial Management LP acquired a new stake in shares of Henry Schein during the fourth quarter valued at about $221,000. Farringdon Capital Ltd. bought a new position in Henry Schein in the 4th quarter valued at approximately $423,000. Ontario Teachers Pension Plan Board acquired a new position in Henry Schein in the 4th quarter valued at approximately $289,000. Guggenheim Capital LLC raised its stake in shares of Henry Schein by 2.5% during the fourth quarter. Guggenheim Capital LLC now owns 6,428 shares of the company's stock valued at $445,000 after acquiring an additional 159 shares during the last quarter. Finally, Canada Post Corp Registered Pension Plan acquired a new position in shares of Henry Schein during the fourth quarter worth $95,000. Institutional investors and hedge funds own 96.62% of the company's stock.

Analyst Upgrades and Downgrades

Several brokerages recently issued reports on HSIC. Barrington Research reaffirmed an "outperform" rating and set a $90.00 target price on shares of Henry Schein in a research report on Wednesday, February 26th. UBS Group decreased their target price on shares of Henry Schein from $83.00 to $80.00 and set a "neutral" rating for the company in a research report on Wednesday, February 26th. StockNews.com cut shares of Henry Schein from a "buy" rating to a "hold" rating in a research report on Thursday, April 17th. Bank of America upgraded shares of Henry Schein from an "underperform" rating to a "buy" rating and boosted their target price for the company from $69.00 to $84.00 in a report on Monday, January 6th. Finally, Jefferies Financial Group increased their price target on Henry Schein from $77.00 to $80.00 and gave the stock a "hold" rating in a report on Thursday, January 23rd. Six research analysts have rated the stock with a hold rating, five have given a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the company has an average rating of "Moderate Buy" and an average target price of $81.10.

Insider Activity

In other news, CEO Bradford C. Connett sold 4,036 shares of the stock in a transaction that occurred on Wednesday, March 19th. The shares were sold at an average price of $71.15, for a total transaction of $287,161.40. Following the completion of the transaction, the chief executive officer now directly owns 62,688 shares of the company's stock, valued at $4,460,251.20. This represents a 6.05 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Philip A. Laskawy sold 2,604 shares of the firm's stock in a transaction that occurred on Wednesday, March 19th. The stock was sold at an average price of $71.04, for a total transaction of $184,988.16. Following the sale, the director now owns 24,805 shares of the company's stock, valued at approximately $1,762,147.20. The trade was a 9.50 % decrease in their position. The disclosure for this sale can be found here. Insiders own 1.14% of the company's stock.

Henry Schein Stock Up 0.7 %

Henry Schein stock traded up $0.43 during midday trading on Thursday, hitting $65.92. 183,731 shares of the stock were exchanged, compared to its average volume of 1,609,181. Henry Schein, Inc. has a 52-week low of $60.56 and a 52-week high of $82.49. The company has a quick ratio of 0.82, a current ratio of 1.42 and a debt-to-equity ratio of 0.46. The business's 50-day moving average price is $69.66 and its 200-day moving average price is $71.83. The stock has a market capitalization of $8.08 billion, a price-to-earnings ratio of 27.13, a price-to-earnings-growth ratio of 2.13 and a beta of 0.84.

Henry Schein (NASDAQ:HSIC - Get Free Report) last announced its earnings results on Tuesday, February 25th. The company reported $1.19 earnings per share for the quarter, missing analysts' consensus estimates of $1.23 by ($0.04). The business had revenue of $3.19 billion during the quarter, compared to analysts' expectations of $3.25 billion. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. Henry Schein's quarterly revenue was up 5.8% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.66 EPS. On average, research analysts expect that Henry Schein, Inc. will post 4.74 EPS for the current fiscal year.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.